AstraZeneca reported $901M in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 2.47B 1.48B
Alcon AG ALC:SW USD -97000000 213M
Amgen AMGN:US USD 1.62B 527M
Artemis Alpha ATS:LN GBP -26769000 16.52M
AstraZeneca AZN:LN USD 901M 739M
AstraZeneca AZN:SS USD 901M 739M
Astrazeneca AZN:US USD 901M 739M
Bayer BAYN:GR EUR 611M 65M
Biogen BIIB:US USD 550.4M 584.3M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Eli Lilly And LLY:US USD 1.94B 486M
Fresenius FRE:GR EUR 255M 67M
Fresenius Medical Care FME:GR EUR 139M 91.1M
Genmab GEN:DC DKK 584M 2B
Gilead Sciences GILD:US USD 1.64B 149M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Hikma Pharmaceutical HIK:LN USD 15M 158M
Merck MRK:GR EUR 654M 269M
Merk MRK:US USD 3.02B 231M
Novartis NOVN:VX USD 1.47B 107M
Orion ORNBV:FH EUR 31.7M 162.8M
Pfizer PFE:US USD 5B 3.61B
Philips PHIA:NA EUR -105000000 1.22B
Recordati REC:IM EUR 90.05M 35.37M
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Roche Holding ROG:VX 3.89B 4.64B